MEDIXPRO LTDActive

Company number 12893262Private limited companyIncorporated 2020

Key figures

£17,818+83.5%
Net assets 2024/25
+52.7%
Average annual growth 2020/21–2024/25
05 k10 k15 k20 k2020/212021/222022/232023/242024/25

Like most small UK companies, MEDIXPRO LTD does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2024/25
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
020 k40 k60 k2020/212021/222022/232023/242024/25
Filed accounts2020/21–2024/25
2020/212021/222022/232023/242024/25
Total assets4,49114,68710,98412,18851,388
Total liabilities1,2181,5831,5832,47933,570
Net assets / total equity3,27313,1049,4019,70917,818
Average number of employees11111

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Summary: MEDIXPRO LTD

Company

MEDIXPRO LTD is a private limited company registered with Companies House under company number 12893262. It was incorporated on 21 Sep 2020. Its status is active. The registered office is in Reading (RG2). Its nature of business (SIC 2007) is agents involved in the sale of a variety of goods (46190), retail sale of medical and orthopaedic goods in specialised stores (not incl. hearing aids) n.e.c. (47749), temporary employment agency activities (78200), medical nursing home activities (86102).

Accounts

The latest accounts in the database are for 2024/25 (period ending 30 Sep 2025); the company files micro-entity accounts. Net assets were £17,818, up 83.5% on the previous year. Total assets were £51,388 and total liabilities £33,570. The company had an average of 1 employee. Figures are available for 5 financial years (2020/21–2024/25).

Control and charges

One person with significant control is registered.

Filing deadlines

The next accounts are due by 30 Jun 2027. The next confirmation statement is due by 4 Oct 2027.